Navigation Links
Tahoma, Colorado Springs and Salt Lake City Have the Highest Percentage of HIV Patients in the U.S. Who Are Left Untreated

NASHVILLE, Tenn., Sept. 16 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, estimates that Tahoma, WA; Colorado Springs, CO and Salt Lake City, UT have the highest percentage of HIV patients who are left untreated. PatientFinder, HealthLeaders-InterStudy's analytics tool, finds that in these areas, 79 percent, 74 percent and 77 percent, respectively, of HIV positive individuals are not receiving any treatment and have prescription drug insurance.

"The high percentage of untreated patients who have prescription drug insurance in these markets is a great opportunity for pharmaceutical companies wishing to grow their patient base," says Andrew Laubscher, product director, PatientFinder. "Their focus should be on small- and mid-size markets to most effectively drive volume growth among patients who are not receiving treatment."

In addition, there are still an additional nine markets in the United States that have treatment rates below 20%, according to PatientFinder. While there are seven major U.S. markets with HIV treatment rates above 90%, there is a high variation in treatment rates across the U.S. that leave a significant amount of HIV patients untreated.

About PatientFinderPatientFinder covers each of the 50 U.S. states and U.S. metropolitan statistical areas (MSAs) and provides:

  • Disease-specific prevalence numbers for each U.S. state and MSA.
  • Examination of treatment rates for the disease population to create percent treated and percent untreated estimates by state and MSA.
  • Unique analysis of the untreated population examined through a filter of pharmacy benefit coverage. The end result is an estimate of how many patients are untreated but can afford therapy within each territory -- the true local measure of opportunity for pharmaceutical companies.

  • Indications covered in 2010 to include*:

  • Alzheimer's disease
  • Asthma
  • Bipolar depression
  • Chronic obstructive pulmonary disease
  • Crohn's disease
  • Dyslipidemia
  • Hepatitis C virus
  • HIV
  • Hypertension
  • Major depression
  • Multiple sclerosis
  • Parkinson's disease
  • Psoriasis
  • Rheumatoid arthritis
  • Schizophrenia
  • Type 2 diabetes (non-insulin)
  • Ulcerative colitis

  • *Indications subject to change.

    Why Pharmaceutical Companies Need This InformationWith the type of information included in PatientFinder, pharmaceutical organizations can identify the local markets that offer the greatest opportunity for their branded drug. Companies can identify markets that are underserved and determine if they should increase direct-to-consumer advertising, work with the local managed care organizations to increase awareness of the disease and benefits of their drug or align sales representatives to maximize market potential.

    About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit

    About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Erin O'Leary

    Elizabeth MarshallHealthLeaders-InterStudy

    Decision Resources, Inc.781-993-2641

    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. CO-REC Ready to Assist Colorado Health Care Providers in Implementing Electronic Health Record Systems and Achieving Meaningful Use
    2. Forensic Laboratories Selected for Colorado Companies to Watch Award
    3. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
    4. Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings
    5. Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens
    6. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
    7. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
    8. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
    9. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
    10. Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy
    11. Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
    Post Your Comments:
    (Date:11/25/2015)... -- Today AVACEN Medical announced the issue of United States patent No. 9,192,509 ... This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods of ... Photo - ... ... ...
    (Date:11/25/2015)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ENL) ... CEO, will discuss corporate updates at the 27 th ... on Wednesday, December 2, 2015 at 1 p.m. ... and then the link to the event. Participants should allow ... visit the site and download any streaming media software needed ...
    (Date:11/25/2015)... November 25, 2015 --> ... blood glucose devices was valued at $11,171.1 million in ... CAGR of 5.7% during 2015 - 2022. The global ... increasing prevalence of diabetes. In addition, the increase in ... also contributing to the growth of the market. Furthermore, ...
    Breaking Medicine Technology:
    (Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
    (Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
    (Date:11/24/2015)... ... ... DMG Productions announced that they will feature Aphria, Inc., in an upcoming episode ... and show times TBA. , Aphria, Inc., is a publicly traded company incorporated under ... medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). , Aphria ...
    (Date:11/24/2015)... ... ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, Dec. ... has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls under ... the device regulations. , Come up short in an inspection and the FDA can ...
    (Date:11/24/2015)... ... November 24, 2015 , ... ... organization will waive paid entry and parking fees at several of their most ... Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. The ...
    Breaking Medicine News(10 mins):